BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zheng NN, Zhou M, Sun F, Huai MX, Zhang Y, Qu CY, Shen F, Xu LM. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression. World J Gastroenterol 2020; 26(26): 3737-3749 [PMID: 32774054 DOI: 10.3748/wjg.v26.i26.3737]
URL: https://www.wjgnet.com/1007-9327/full/v26/i26/3737.htm
Number Citing Articles
1
Yuanling Zhang, Junhao Chen, Hang Liu, Rui Mi, Rui Huang, Xian Li, Fei Fan, Xueqing Xie, Jie Ding. The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapyFrontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1099892
2
Wenhao Luo, Lianfang Zheng, Taiping Zhang. Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapyInternational Immunopharmacology 2021; 90: 107199 doi: 10.1016/j.intimp.2020.107199
3
Zhanbo Sun, Lixian Liu, Jun Chen. Targeting non-histone methylation in gastrointestinal cancers: From biology to clinicEuropean Journal of Medicinal Chemistry 2024; 278: 116802 doi: 10.1016/j.ejmech.2024.116802
4
Stephanie Hufnagel, Haiyue Xu, Michael F. Colemam, Solange A. Valdes, Kristyn A. Liu, Stephen D. Hursting, Zhengrong Cui. 4-(N)-Docosahexaenoyl 2’, 2’-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agentCancer Chemotherapy and Pharmacology 2022; 89(1): 59 doi: 10.1007/s00280-021-04367-2
5
Kritisha Bhandari, Wei-Qun Ding. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for TherapyInternational Journal of Molecular Sciences 2024; 25(7): 3958 doi: 10.3390/ijms25073958
6
Hong-Bo Li, Zi-Han Yang, Qing-Qu Guo. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic reviewCell Communication and Signaling 2021; 19(1) doi: 10.1186/s12964-021-00789-w
7
Samyuktha Suresh, Solène Huard, Amélie Brisson, Fariba Némati, Rayan Dakroub, Coralie Poulard, Mengliang Ye, Elise Martel, Cécile Reyes, David C. Silvestre, Didier Meseure, André Nicolas, David Gentien, Hussein Fayyad-Kazan, Muriel Le Romancer, Didier Decaudin, Sergio Roman-Roman, Thierry Dubois. PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast CancerCancers 2022; 14(2): 306 doi: 10.3390/cancers14020306
8
Ming Li Jin, Kwang Won Jeong. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspectiveExperimental & Molecular Medicine 2023; 55(7): 1333 doi: 10.1038/s12276-023-01014-z
9
Yaolin Xu, Lijie He, Qiang Fu, Junzhe Hu. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune CheckpointsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.759015
10
Bin Wang, Dong Ding, Xiaoan Zhang, Junxi Zhang, Huanhuan Zhang, Xinxin Liu, Hui Chang, Zhan Gao, Zengli Yu. The Role of Protein Arginine Methyltransferases in Pathogenesis and Treatment of Digestive System CarcinomaMolecular Cancer Therapeutics 2023; 22(8): 926 doi: 10.1158/1535-7163.MCT-22-0746
11
Jian Xu, Stéphane Richard. Cellular pathways influenced by protein arginine methylation: Implications for cancerMolecular Cell 2021; 81(21): 4357 doi: 10.1016/j.molcel.2021.09.011
12
Jin Zou, Wei Shen, Yu Zhang, Shibo Ying. Post-Translational Modifications in Cellular Functions and Diseases2021;  doi: 10.5772/intechopen.96197
13
Jia Yan, Ke xin Li, Lei Yu, Heng Yuan, Zhi Zhao, Jing Lin, Chang Shan Wang. PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2024; : 15 doi: 10.2147/JHC.S443130
14
Yutong Zhao, Cheng Qin, Chen Lin, Zeru Li, Bangbo Zhao, Tianyu Li, Xiangyu Zhang, Weibin Wang. Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targetsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(6): 189183 doi: 10.1016/j.bbcan.2024.189183
15
Ao-Yu Li, Hui-Ni Xiao, Zi-Yue Zhao, Cheng Xiang, Zhuo-yuan Chen, Ping-xiao Wang, Yu Xia, Bin Yu, Hui Li, Tao Xiao. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validationJournal of Cancer Research and Clinical Oncology 2023; 149(11): 9105 doi: 10.1007/s00432-023-04849-1
16
Tianli Zhang, Mengmeng Liu, Qing Liu, Gary Guishan Xiao. Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathwayFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1068855
17
Weijing Dai, Jianguo Zhang, Siqi Li, Fajian He, Qiao Liu, Jun Gong, Zetian Yang, Yan Gong, Fang Tang, Zhihao Wang, Conghua Xie. Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and ImmunotherapyFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865964
18
Zhe-Nan Ling, Yi-Fan Jiang, Jun-Nan Ru, Jia-Hua Lu, Bo Ding, Jian Wu. Amino acid metabolism in health and diseaseSignal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-023-01569-3
19
Sara A. Murphy, Norman John Mapes, Devika Dua, Balveen Kaur. Histone modifiers at the crossroads of oncolytic and oncogenic virusesMolecular Therapy 2022; 30(6): 2153 doi: 10.1016/j.ymthe.2022.02.006
20
Jean-Paul Bryant, John Heiss, Yeshavanth Kumar Banasavadi-Siddegowda. Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic StrategiesCells 2021; 10(1): 124 doi: 10.3390/cells10010124
21
Nivine Srour, Sarah Khan, Stephane Richard. The Influence of Arginine Methylation in Immunity and InflammationJournal of Inflammation Research 2022; : 2939 doi: 10.2147/JIR.S364190
22
Ying Xu, Qing Zhu. Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic CancerInternational Journal of Molecular Sciences 2023; 24(5): 4820 doi: 10.3390/ijms24054820
23
Jemma Arakelyan, Daniil A. Rusanov, Meng Rui Chang, Aleksandra V. Asaturova, Galina S. Kireeva, Mana Alshehri, Wee Han Ang, Maria V. Babak. Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part IICoordination Chemistry Reviews 2023; 475: 214899 doi: 10.1016/j.ccr.2022.214899
24
Kazumichi Kawakubo, Carlos Fernandez-del Castillo, Andrew Scott Liss. Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapyJournal of Gastroenterology 2022; 57(11): 819 doi: 10.1007/s00535-022-01915-2